Please assess the completion status of the following clinical trial:

Trial Title: Influenza Vaccination in Immunocompromized Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult outpatients treated at the Inselspital Bern for:~* HIV infection~* rheumatologic diseases and receiving immunosuppressive drugs~* kidney transplant recipients~* undergoing hemodialysis or continuous ambulatory peritoneal dialysis~* written informed consent~Exclusion Criteria:~* Allergy to egg proteins~* Former adverse reactions to prior vaccination~* Febrile conditions at the time of study inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Virosomal influenza vaccine (Type: EXPERIMENTAL): None
- Subunit influenza vaccine (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).